Gesynta Pharma

Stockholm, Sweden · Founded 2017 · Privately Held (backing)

Developer of a clinical-stage pharmaceutical portfolio designed to treat inflammatory diseases by inhibiting pro-inflammatory pathways. Gesynta Pharma is based in Stockholm, Sweden and was founded in 2017. Its last reported valuation was $42.8 million in Dec 2021. It has raised $77.8 million.

Last reported valuation
$42.8M
Oct 2026
Priced at
—
Total raised
$77.8M
Last round
—

Who backs Gesynta Pharma?

17 investors
InvestorType
InnovestorVenture capital
IndustrifondenVenture capital
Nordic Mentor Network For EntrepreneurshipOther
Amboy Street VenturesVenture capital
Stephen IndustriesOther
CTI Life Sciences Fund—
Catalyze-Capital—
DRIVE ( KI Innovations Business Incubator)—
Foreground Capital—
Hadean Ventures—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gesynta Pharma investors

17 investors are on record for Gesynta Pharma, including Innovestor, Industrifonden, Nordic Mentor Network For Entrepreneurship and Amboy Street Ventures.

Free account
More of Gesynta Pharma with a free account
  • ·The complete investor list: 17 names
  • ·Watch Gesynta Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Gesynta Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View